Form 4: Tango Therapeutics Director John B Ketchum Reports Acquisition of Shares and Stock Options
SEC Form 4 Filing
Director John B Ketchum reports acquiring shares and stock options in Tango Therapeutics, Inc.
Summary
- On June 5, 2024, John B Ketchum, a director of Tango Therapeutics, Inc., reported acquiring 4,687 shares of common stock and 28,125 stock options.
- The shares were acquired through restricted stock units (RSUs) at a price of $0.00.
- The stock options have an exercise price of $7.41 and will vest in 12 equal monthly installments starting July 5, 2024, expiring on June 5, 2034.
- Following the transaction, Ketchum beneficially owns 14,687 shares of common stock and 28,125 stock options.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a standard regulatory filing. The acquisition of shares and options by a director is generally viewed as a positive sign, but it's not a major event.
Positives
- The acquisition of shares and options by a director could be seen as a positive signal, indicating confidence in the company's future prospects.
Future Outlook
The vesting schedule of the RSUs and stock options is contingent upon the Reporting Person's continuous service with the Issuer.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track management's sentiment and alignment with shareholder interests.
Stakeholder Impact
- Shareholders may view the director's acquisition of shares and options as a positive signal.
Key Dates
| Date | Description |
|---|---|
| 06/05/2024 | Date of transaction: Acquisition of common stock and stock options. |
| 06/05/2025 | RSUs will vest in its entirety on the earlier of: (i) June 5, 2025 and (iii) the date of the next annual meeting of stockholders |
| 07/05/2024 | Stock options vest in 12 substantially equal monthly installments over a period of one year beginning on this date. |
| 06/05/2034 | Expiration date of the stock options. |
| 06/07/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.